Annick Moens

487 total citations
17 papers, 207 citations indexed

About

Annick Moens is a scholar working on Epidemiology, Immunology and Surgery. According to data from OpenAlex, Annick Moens has authored 17 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Immunology and 7 papers in Surgery. Recurrent topics in Annick Moens's work include Microscopic Colitis (7 papers), Inflammatory Bowel Disease (6 papers) and Eosinophilic Esophagitis (4 papers). Annick Moens is often cited by papers focused on Microscopic Colitis (7 papers), Inflammatory Bowel Disease (6 papers) and Eosinophilic Esophagitis (4 papers). Annick Moens collaborates with scholars based in Belgium, United States and Switzerland. Annick Moens's co-authors include Marc Ferrante, Séverine Vermeire, Gert Van Assche, João Sabino, Anthony de Buck van Overstraeten, André D’Hoore, Bram Verstockt, Albert Wolthuis, Peter Bossuyt and Dahham Alsoud and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Inflammatory Bowel Diseases.

In The Last Decade

Annick Moens

14 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annick Moens Belgium 8 132 115 86 67 55 17 207
Evelien Humblet Belgium 5 185 1.4× 143 1.2× 68 0.8× 88 1.3× 44 0.8× 10 248
Ilia Tikhonov United States 8 172 1.3× 136 1.2× 91 1.1× 90 1.3× 47 0.9× 14 282
Aimee Blake United Kingdom 8 195 1.5× 152 1.3× 109 1.3× 100 1.5× 81 1.5× 23 286
Ohad Atia Israel 10 221 1.7× 166 1.4× 83 1.0× 36 0.5× 40 0.7× 37 269
Laura Armengol‐Debeir France 8 272 2.1× 171 1.5× 169 2.0× 43 0.6× 33 0.6× 15 355
Martin Lukáš Czechia 9 150 1.1× 108 0.9× 103 1.2× 195 2.9× 120 2.2× 30 304
José Lázaro Pérez‐Calle Spain 6 161 1.2× 116 1.0× 67 0.8× 126 1.9× 67 1.2× 9 274
Bénédicte De Vroey France 8 128 1.0× 131 1.1× 95 1.1× 104 1.6× 83 1.5× 17 312
Noémie Tavernier France 3 150 1.1× 109 0.9× 86 1.0× 80 1.2× 93 1.7× 3 231
Mohamed Attauabi Denmark 8 156 1.2× 105 0.9× 62 0.7× 33 0.5× 13 0.2× 42 252

Countries citing papers authored by Annick Moens

Since Specialization
Citations

This map shows the geographic impact of Annick Moens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Moens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Moens more than expected).

Fields of papers citing papers by Annick Moens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Moens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Moens. The network helps show where Annick Moens may publish in the future.

Co-authorship network of co-authors of Annick Moens

This figure shows the co-authorship network connecting the top 25 collaborators of Annick Moens. A scholar is included among the top collaborators of Annick Moens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick Moens. Annick Moens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Moens, Annick, P. N. Adama van Scheltema, Esther Sikkel, et al.. (2025). Clinical Outcome and Risk Factors for Progression of Prenatally Diagnosed Fetal Ventriculomegaly: A Retrospective Multicenter Study. Prenatal Diagnosis. 45(9). 1089–1099.
3.
Vanoli, Alessandro, Giovanni Arpa, Catherine Klersy, et al.. (2023). Mismatch repair deficiency as prognostic factor for stage III small bowel adenocarcinoma: A multicentric international study. Digestive and Liver Disease. 55(9). 1261–1269. 1 indexed citations
4.
Moens, Annick, et al.. (2022). Safety of sequential biological therapy in inflammatory bowel disease: results from a tertiary referral centre. Alimentary Pharmacology & Therapeutics. 56(2). 271–281.
5.
Moens, Annick, Dahham Alsoud, Bram Verstockt, et al.. (2022). Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn’s disease: real-life cohort from a tertiary referral center. European Journal of Gastroenterology & Hepatology. 34(10). 1015–1020. 13 indexed citations
6.
Vieujean, Sophie, Annick Moens, Katja Rothfuss, et al.. (2022). Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease–a Case Series. Journal of Crohn s and Colitis. 17(4). 472–479. 3 indexed citations
7.
Moens, Annick, Bram Verstockt, Dahham Alsoud, et al.. (2021). Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD. Inflammatory Bowel Diseases. 28(8). 1135–1142. 16 indexed citations
8.
Moens, Annick, et al.. (2020). Long‐term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort. United European Gastroenterology Journal. 8(8). 933–941. 19 indexed citations
9.
Restellini, Sophie, Luc Biedermann, Petr Hrúz, et al.. (2020). Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding. Digestion. 101(Suppl. 1). 27–42. 25 indexed citations
10.
Vieujean, Sophie, Annick Moens, Katja Rothfuss, et al.. (2019). P697 Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s). Journal of Crohn s and Colitis. 13(Supplement_1). S468–S469.
11.
Moens, Annick, Bram Verstockt, Kathleen Machiels, et al.. (2019). Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades. European Journal of Gastroenterology & Hepatology. 31(6). 668–673. 14 indexed citations
12.
Bronswijk, Michiel, Annick Moens, Sophie Tops, et al.. (2019). Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center. Inflammatory Bowel Diseases. 26(1). 161–161. 17 indexed citations
13.
Moens, Annick, Karen van Hoeve, Evelien Humblet, et al.. (2018). OP032 Outcome of pregnancies in female IBD patients treated with vedolizumab. Journal of Crohn s and Colitis. 12(supplement_1). S022–S023. 7 indexed citations
14.
Moens, Annick, Karen van Hoeve, Evelien Humblet, et al.. (2018). Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab. Journal of Crohn s and Colitis. 13(1). 12–18. 40 indexed citations
15.
Moens, Annick, Karen van Hoeve, Evelien Humblet, et al.. (2018). Sa1697 - Outcome of Pregnancies in Vedolizumab Treated Female IBD Patients. Gastroenterology. 154(6). S–360. 1 indexed citations
16.
Ferrante, Marc, Anthony de Buck van Overstraeten, Annick Moens, et al.. (2017). Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy. Journal of Crohn s and Colitis. 11(11). 1353–1361. 48 indexed citations
17.
Moens, Annick, et al.. (2009). Epididymo-Orchitis due to Brucellosis: Not Only to Be Considered in Endemic Areas. Urologia Internationalis. 82(4). 481–483. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026